CALIFORNIA | LOCAL
May 24, 2006 |
Nearly 1,300 inmates at nine California prisons have been stricken with gastroenteritis, according to corrections officials, who remain stumped by the source of the bacterial outbreak. Some inmates have been hospitalized, but most have been treated in their cells for vomiting, fever, headaches, diarrhea and cramping caused by Campylobacter bacteria. A small number of staff members also have become ill.
December 1, 1996
AMDL Inc., a biomedical company, said the Food and Drug Administration asked the firm to withdraw its application to sell a test for a stomach-irritating bacteria until it provides additional clinical data. AMDL's test, PyloriProbe, is designed to detect the presence of H. pylori, which is associated with ulcers. AMDL said additional studies of PyloriProbe are in progress and that it plans to resubmit its application with the FDA. PyloriProbe is only available for distribution outside the U.S.
CALIFORNIA | LOCAL
April 18, 1996 |
Long-term use of a widely prescribed heartburn drug called Prilosec may be hazardous if patients are also infected with a common bacterium linked to both stomach ulcers and cancer. Although the drug relieves severe heartburn by suppressing the production of stomach acid, the lower acid levels allow the bacteria to cause more inflammation, a Dutch team reports in the April 18 issue of the New England Journal of Medicine.
April 1, 2002 |
Botox is remarkably safe, especially considering it's a powerful toxin. Occasionally, a mild headache that lasts a few hours may occur after an injection in muscles of the forehead. Very rarely, though, that headache may become excruciating and can last as long as a month.
October 6, 1998
ICN Pharmaceuticals Inc., moving to offset business setbacks in Eastern Europe, said it's buying global rights to four medicines from Swiss drug giant Roche Holdings for $179 million in cash and stock. Costa Mesa-based ICN is acquiring rights to Dalmodorm, a drug for sleep disorders; Fluoro-Uracil, a treatment for cancer; Librax, for gastrointestinal disorders; and Mogadon, a sleep-disorder drug used to treat epilepsy. The drugs are expected to generate sales of about $67 million a year.
August 4, 2007 |
Elderly African Americans who are chronic users of acidinhibiting medications in the family that includes Zantac, Pepcid and Tagamet have 2 1/2 times the normal risk of developing dementia, Indiana researchers reported Friday. The drugs block production of stomach acid by inhibiting so-called histamine-2 receptors; a pump in the stomach releases hydrochloric acid when stimulated by histamines. But they also inhibit the brain's cholinergic system, which is involved in memory and cognition.